GRI Bio, Inc. (GRI) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.23M | +63.7% |
| 2024 | $5.03M | +178.1% |
| 2023 | $1.81M | +19988.9% |
| 2022 | $9.0K | -99.8% |
| 2021 | $3.70M | +3296.3% |
| 2020 | $109.0K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.23M | +63.7% |
| 2024 | $5.03M | +178.1% |
| 2023 | $1.81M | +19988.9% |
| 2022 | $9.0K | -99.8% |
| 2021 | $3.70M | +3296.3% |
| 2020 | $109.0K | — |